Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection

Generally, tyrosine kinase inhibitors have narrow therapeutic window and large interpatient variability compared to intrapatient variability. In order to support its therapeutic drug monitoring, two fast and accurate methods were developed for the determination of recently FDA approved anticancer ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouad, Marwa, Helvenstein, Maxime, Blankert, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458533/
https://www.ncbi.nlm.nih.gov/pubmed/26101692
http://dx.doi.org/10.1155/2015/215128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458533/
https://www.ncbi.nlm.nih.gov/pubmed/26101692
http://dx.doi.org/10.1155/2015/215128

Ejemplares similares